Accessibility Menu

PetMed Express(FRA) PQM

Market Cap€32.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€1.53
+0.66%
+0.01Today

PetMed Express Financials at a Glance

Market Cap

€32.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€144.77

Net Income (TTM)

-€25.11

EPS (TTM)

-€1.19

P/E Ratio

-1.28

Dividend

€0.00

Beta (Volatility)

0.03 (Low)

Price

€1.53

Volume

0

Open

€1.53

Previous Close

€1.52

Daily Range

€1.53 - €1.53

52-Week Range

€1.27 - €3.28

Estimated Earnings Date

N/A

PQM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PetMed Express

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

Industry

Specialty Retail

Employees

189

CEO

Leslie C. G. Campbell

PQM Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-78.46%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-78.13%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€32.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

21.68M

Volume

0

Avg. Volume

65.258

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

PetMed Express Performance Analysis

PetMed Express annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31EUR 246,657,4274.8%
20242024-03-31EUR 252,796,9562.5%
20252025-03-31EUR 211,420,326-16.4%
20262026-03-31EUR 154,498,541-26.9%
PetMed Express annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31EUR 0.24-72.8%
20242024-03-31EUR -0.34N/A
20252025-03-31EUR -0.28-16.0%
20262026-03-31EUR -2.36733.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€35.28

+0.8%

Gross Profit

€7.90

+0.7%

Gross Margin

22.39%

+0.9%

Market Cap

€32.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.17

N/A

Employees

189

N/A

Net Income

-€5.29

+0.2%

EBITDA

-€3.51

+0.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€11.80

-67.0%

Total Debt

€0.36

+0.5%

Accounts Receivable

€1.49

+1.1%

Inventory

€7.41

+0.5%

Long Term Debt

€0.00

+0.0%

Short Term Debt

€0.36

+0.9%

Return on Assets

-33.63%

+1.0%

Return on Invested Capital

-38.62%

N/A

Free Cash Flow

-€7.16

+0.6%

Operating Cash Flow

-€6.61

+0.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$219.51-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.53-0.04%
BIAFbioAffinity Technologies
$6.91+0.52%
INTCIntel
$89.07-0.00%

Questions About PQM

What is the current price of PetMed Express?

PetMed Express is trading at €1.53 per share.

What is the 52-week range for PetMed Express?

Over the past 52 weeks, PetMed Express has traded between €1.27 and €3.28.

How much debt does PetMed Express have?

As of the most recent reporting period, PetMed Express reported total debt of €362.11K.

How much cash does PetMed Express have on hand?

PetMed Express reported €11.44M in cash and cash equivalents in its most recent financial results.

What is PetMed Express’s dividend yield?

PetMed Express does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.